Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01940172 |
Title | Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer |
Recruitment | Completed |
Gender | female |
Phase | Phase I |
Variant Requirements | No |
Sponsors | TetraLogic Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |